Collins Stewart Reiterates a 'Buy' on Valeant Pharmaceuticals (VRX); Weakness Related To CEPH Is A Good Buying Opportunity

Go back to Collins Stewart Reiterates a 'Buy' on Valeant Pharmaceuticals (VRX); Weakness Related To CEPH Is A Good Buying Opportunity
Cephalon, Inc. (NASDAQ: CEPH) Delayed: 81.49 --0 (-0%)
Previous Close $81.49    52 Week High $81.49 
Open $3.97    52 Week Low $54.15 
Day High $81.49    P/E 11.98 
Day Low $81.49    EPS $6.80 
Volume 1,914       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.77 +0.25 (0.68%)
Previous Close $36.52    52 Week High $66.55 
Open $36.26    52 Week Low $37.82 
Day High $36.81    P/E N/A 
Day Low $36.09    EPS $0.00 
Volume 2,332,461       

VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) Delayed: 23.40 --0 (-0%)
Previous Close $23.40    52 Week High $119.86 
Open $23.40    52 Week Low $13.77 
Day High $23.40    P/E N/A 
Day Low $23.40    EPS $0.00 
Volume 378,733